Reviva Pharmaceuticals Hldg Inc (RVPH)

$0.67 +0.13 (22.94%)
Market Cap 37.79M
Revenue (ttm) 0.00
Net Income (ttm) -29.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 38,286,000
Avg Vol 5,566,584
Day's Range N/A - N/A
Shares Out 69.34M
Stochastic %K 88%
Beta -0.08
Analysts Strong Sell
Price Target $6.25

Company Profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity...

Industry: Biotechnology
Sector: Healthcare
Phone: 408-501-8881
Fax: 408-904-6270
Address:
10080 N. Wolfe Road, Suite SW3-200, Cupertino, United States
FlyingSheet
FlyingSheet Oct. 7 at 6:53 AM
$RVPH what's happening on thev9th?
0 · Reply
FlyingSheet
FlyingSheet Oct. 7 at 6:51 AM
$RVPH when do we expect fda appeoval??
1 · Reply
GordonGekko00007
GordonGekko00007 Oct. 7 at 5:25 AM
$RVPH So in other words market cap is not a problem anymore 🤫
0 · Reply
Deniz46000
Deniz46000 Oct. 7 at 5:24 AM
$RVPH Reviva fam, are you ready PM?? 🚀
0 · Reply
RipplingMangekyo
RipplingMangekyo Oct. 7 at 5:13 AM
PRHI is setting up for a crazy run tomorrow. Don't miss the opportunity to bank on it. PRHI if u check the chart, ran to $3+ not too long ago. This time I think we can see a even bigger move!! Market has been been sending tickers up 500-600%+, PRHI can do the same, retails is coming together on this!! $BURU $OPEN $RVPH $BOXL...
0 · Reply
PaulLaurent
PaulLaurent Oct. 7 at 5:11 AM
🚀📈 Top Gainers 📈🚀 AH $SPRB $NAK $PRHI $PCSA $RVPH
0 · Reply
LoneWolfBanks
LoneWolfBanks Oct. 7 at 4:48 AM
I found a stock that is about to absolutely explode tomorrow. Check out PRHI🚨🚀 All eyes on PRHI Don't be late bulls!! PRPH ✅Low float 3.8M ✅No dilution filed ✅12M in cash ✅40k shorts left (from 132k at 4pm) ✅ 66M in revenues in 2024 ✅ Only 15M market cap Closed at $1.75 in afterhours! Over $2.20, could fly to $4+ $APP $RVPH $SERV $LAES ..
0 · Reply
mystic_13
mystic_13 Oct. 7 at 4:42 AM
$RVPH Maybe a repeat of this is in the works, who knows:
0 · Reply
mystic_13
mystic_13 Oct. 7 at 4:26 AM
$RVPH https://www.reddit.com/r/pennystocks/comments/1nzz5s5/the_rest_of_the_year_will_be_huge_for_rvph_300/
0 · Reply
Jesse1011
Jesse1011 Oct. 7 at 4:03 AM
$RVPH shorts are sooo screwed!!!! Been doubling down! What do yall think is going to happen when they return shares 🔥🔥🔥😜😜😜
0 · Reply
Latest News on RVPH
Top 3 Health Care Stocks That May Explode In September

Sep 19, 2025, 7:01 AM EDT - 17 days ago

Top 3 Health Care Stocks That May Explode In September

ATYR BSX

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

Sep 18, 2025, 9:26 PM EDT - 18 days ago

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Sep 18, 2025, 4:05 PM EDT - 18 days ago

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 14, 2025, 4:25 PM EDT - 7 weeks ago

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering

Jun 26, 2025, 8:40 AM EDT - 3 months ago

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering

Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 5, 2025, 8:00 AM EDT - 4 months ago

Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Jun 2, 2025, 7:00 AM EDT - 4 months ago

Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 15, 2025, 4:05 PM EDT - 5 months ago

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Mar 30, 2025, 11:30 AM EDT - 6 months ago

Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 4, 2025, 8:00 AM EST - 8 months ago

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Reviva to Participate in the 2025 BIO CEO & Investor Conference

Jan 30, 2025, 8:00 AM EST - 8 months ago

Reviva to Participate in the 2025 BIO CEO & Investor Conference

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

Jan 7, 2025, 8:00 AM EST - 9 months ago

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

Reviva Announces Proposed Public Offering

Dec 16, 2024, 5:18 PM EST - 10 months ago

Reviva Announces Proposed Public Offering

Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low

Dec 11, 2024, 3:37 PM EST - 10 months ago

Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 14, 2024, 5:25 PM EST - 11 months ago

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

Nov 6, 2024, 8:00 AM EST - 11 months ago

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

Reviva to Participate in the UBS Global Healthcare Conference

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Reviva to Participate in the UBS Global Healthcare Conference

Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 8:00 AM EDT - 1 year ago

Reviva to Participate in the 2024 Maxim Healthcare Virtual Summit

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 8:30 AM EDT - 1 year ago

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules

Aug 21, 2024, 6:00 AM EDT - 1 year ago

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

May 29, 2024, 4:45 PM EDT - 1 year ago

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

May 28, 2024, 8:00 AM EDT - 1 year ago

Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Reviva to Participate in the BIO International Convention

May 21, 2024, 8:00 AM EDT - 1 year ago

Reviva to Participate in the BIO International Convention

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

May 15, 2024, 8:00 AM EDT - 1 year ago

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 14, 2024, 8:00 AM EDT - 1 year ago

Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference

May 13, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference

Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting

May 9, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

Apr 15, 2024, 8:05 AM EDT - 1 year ago

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

Mar 26, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

Reviva to Present at the UBS Virtual CNS Day

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Reviva to Present at the UBS Virtual CNS Day

Reviva to Present at the 36th Annual ROTH Conference

Mar 7, 2024, 8:00 AM EST - 1 year ago

Reviva to Present at the 36th Annual ROTH Conference

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Feb 20, 2024, 8:00 AM EST - 1 year ago

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Feb 6, 2024, 8:00 AM EST - 1 year ago

Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Jan 25, 2024, 8:00 AM EST - 1 year ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

Jan 10, 2024, 8:00 AM EST - 1 year ago

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

Jan 4, 2024, 8:00 AM EST - 1 year ago

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

Dec 11, 2023, 8:00 AM EST - 1 year ago

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Nov 30, 2023, 4:05 PM EST - 2 years ago

Reviva Pharmaceuticals to Participate in The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 20, 2023, 4:05 PM EST - 2 years ago

Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2023, 8:00 AM EST - 2 years ago

Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 14, 2023, 4:01 PM EST - 2 years ago

Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals: Positive Results In Phase 3 But The Stock Is Back Where It Started

Nov 2, 2023, 3:11 AM EDT - 2 years ago

Reviva Pharmaceuticals: Positive Results In Phase 3 But The Stock Is Back Where It Started

Reviva Pharma's schizophrenia drug succeeds in late-stage study

Oct 30, 2023, 7:41 AM EDT - 2 years ago

Reviva Pharma's schizophrenia drug succeeds in late-stage study

Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Oct 30, 2023, 7:30 AM EDT - 2 years ago

Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

Sep 29, 2023, 9:00 AM EDT - 2 years ago

Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV

AREC STSS

FlyingSheet
FlyingSheet Oct. 7 at 6:53 AM
$RVPH what's happening on thev9th?
0 · Reply
FlyingSheet
FlyingSheet Oct. 7 at 6:51 AM
$RVPH when do we expect fda appeoval??
1 · Reply
GordonGekko00007
GordonGekko00007 Oct. 7 at 5:25 AM
$RVPH So in other words market cap is not a problem anymore 🤫
0 · Reply
Deniz46000
Deniz46000 Oct. 7 at 5:24 AM
$RVPH Reviva fam, are you ready PM?? 🚀
0 · Reply
RipplingMangekyo
RipplingMangekyo Oct. 7 at 5:13 AM
PRHI is setting up for a crazy run tomorrow. Don't miss the opportunity to bank on it. PRHI if u check the chart, ran to $3+ not too long ago. This time I think we can see a even bigger move!! Market has been been sending tickers up 500-600%+, PRHI can do the same, retails is coming together on this!! $BURU $OPEN $RVPH $BOXL...
0 · Reply
PaulLaurent
PaulLaurent Oct. 7 at 5:11 AM
🚀📈 Top Gainers 📈🚀 AH $SPRB $NAK $PRHI $PCSA $RVPH
0 · Reply
LoneWolfBanks
LoneWolfBanks Oct. 7 at 4:48 AM
I found a stock that is about to absolutely explode tomorrow. Check out PRHI🚨🚀 All eyes on PRHI Don't be late bulls!! PRPH ✅Low float 3.8M ✅No dilution filed ✅12M in cash ✅40k shorts left (from 132k at 4pm) ✅ 66M in revenues in 2024 ✅ Only 15M market cap Closed at $1.75 in afterhours! Over $2.20, could fly to $4+ $APP $RVPH $SERV $LAES ..
0 · Reply
mystic_13
mystic_13 Oct. 7 at 4:42 AM
$RVPH Maybe a repeat of this is in the works, who knows:
0 · Reply
mystic_13
mystic_13 Oct. 7 at 4:26 AM
$RVPH https://www.reddit.com/r/pennystocks/comments/1nzz5s5/the_rest_of_the_year_will_be_huge_for_rvph_300/
0 · Reply
Jesse1011
Jesse1011 Oct. 7 at 4:03 AM
$RVPH shorts are sooo screwed!!!! Been doubling down! What do yall think is going to happen when they return shares 🔥🔥🔥😜😜😜
0 · Reply
Deniz46000
Deniz46000 Oct. 7 at 4:03 AM
$RVPH $NXXT a surprise to wale up to 🚀🚀
0 · Reply
Jesse1011
Jesse1011 Oct. 7 at 4:01 AM
$RVPH think it will trigger gamma squeeze?
0 · Reply
mystic_13
mystic_13 Oct. 7 at 3:54 AM
$RVPH All eyes on October 9. It's at 8:00 AM ET.
1 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Oct. 7 at 3:42 AM
$RVPH 90 CNTS
0 · Reply
Jesse1011
Jesse1011 Oct. 7 at 3:27 AM
$RVPH anyone buying calls? I’m new to options! What would you suggest I’m new to calls
0 · Reply
BarbarianBill
BarbarianBill Oct. 7 at 3:24 AM
$RVPH wherz that bino mark twat?
1 · Reply
wannaberr
wannaberr Oct. 7 at 3:19 AM
$RVPH Your target price after 9 october?
2 · Reply
TB2025
TB2025 Oct. 7 at 3:17 AM
$RVPH Okay, one more question after the Mike Sibley news at $NBIX . Why hire a top-tier GM/SVP with recent Dermatology experience from Sanofi to run a Neuropsych franchise? $RVPH 's Brilaroxazine secondary imdications trial is in Psoriasis! This perfectly sets Neurocrine up for a huge entry into the Neuropsych and Derm Inflammation space. Acquisition is coming. 🚀💎
0 · Reply
Jesse1011
Jesse1011 Oct. 7 at 3:13 AM
$RVPH anyone have a screenshot of overnight?
2 · Reply
TB2025
TB2025 Oct. 7 at 2:51 AM
$RVPH Could $NBIX Neurocrine hired this new GM today to oversee a new business unit they are taking on with Reviva Pharma and Brilaroxazine???? Typically a new GM added before an acquisition is made....
1 · Reply
DJORCKO
DJORCKO Oct. 7 at 2:49 AM
$RVPH easy 1.50 2+ tomorrow
0 · Reply
wannaberr
wannaberr Oct. 7 at 2:44 AM
$RVPH can’t sleep, hope +1 in these days
0 · Reply